4301 items (4301 unread) in 74 feeds
Acinar Cell Carcinoma
(73 unread)
Acinic Cell Carcinoma
(53 unread)
Adenoid Cystic Carcinoma
(264 unread)
Adrenal Gland Cancer
(299 unread)
Ampulla Of Vater
(55 unread)
Anal Cancer
(374 unread)
Angiosarcoma
(75 unread)
Appendix Cancer
(95 unread)
Bile Duct Cancer
(420 unread)
Brain and CNS
(464 unread)
Carcinoid
(70 unread)
Endocrine/Neuroendocrine
(637 unread)
Gall Bladder Cancer
(90 unread)
Hemangioendothelioma
(149 unread)
Hepatoblastoma
(67 unread)
Pancreas
(72 unread)
Phyllodes
(61 unread)
PMP and Mucinous Tumors
(79 unread)
Rhabdomyosarcoma
(96 unread)
Sarcoma
(808 unread)
Clin Case Rep. 2022 Dec 12;10(12):e6718. doi: 10.1002/ccr3.6718. eCollection 2022 Dec.
ABSTRACT
This 38-year-old man has a familial BRCA2 mutation. He presented with skin erythema, polyarthritis, dactylitis, and febrile erythema nodosum; a biopsy of a liver metastase revealed acinar cell carcinoma of the pancreas. After FOLFIRINOX, olaparib was initiated, and 24 months after, the patient was PS 0 and asymptomatic.
PMID:36523391 | PMC:PMC9744715 | DOI:10.1002/ccr3.6718
Clin Case Rep. 2022 Dec 12;10(12):e6718. doi: 10.1002/ccr3.6718. eCollection 2022 Dec.
ABSTRACT
This 38-year-old man has a familial BRCA2 mutation. He presented with skin erythema, polyarthritis, dactylitis, and febrile erythema nodosum; a biopsy of a liver metastase revealed acinar cell carcinoma of the pancreas. After FOLFIRINOX, olaparib was initiated, and 24 months after, the patient was PS 0 and asymptomatic.
PMID:36523391 | PMC:PMC9744715 | DOI:10.1002/ccr3.6718
